Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itraconazole for Hedgehog Inhibition in Esophageal Cancer
NCT02749513Phase 1Unknown
- Sponsor
- Dallas VA Medical Center
- Start
- Jan 2016
- Primary completion
- Sep 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of itraconazole in esophageal cancer, sponsored by Dallas VA Medical Center. Primary endpoint: Inhibition of Hedgehog pathway signaling. Status: unknown.
02
Drugs
itraconazole
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT02749513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02749513.